UNSPSC 51162740: Tasuldine

This classification denotes a mucolytic agent with the molecular formula C10H9N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) S4ZCE64Q3O, chemically known as pyrimidine, 2-((3-pyridinylmethyl)thio)- but more generally known as tasuldine, which bears US NIH Compound Identifier 65666. European Medicines Agency schedules Tasuldine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10835MIG. The term TASULDINE is an International Non-Proprietary Name.

UNSPSC 51162740 Tasuldine, a Commodity code, covers pharmaceutical and medical products supplied to state and local health, corrections, and public-health agencies. State and local governments buy injectable pharmaceutical solutions, IV nutrition products, opioid antagonists, and related medical consumables under this code — specifically parenteral nutrition preparations (TPN and PPN), intravenous solutions, naloxone, and drug-deactivation systems delivered on rapid cycles to correctional facilities, county health departments, and emergency-response programs. The issuing bodies include state departments of corrections, county health and emergency-management agencies, and municipal or special-purpose public-health programs. Vendors must hold appropriate state business licenses, pass background clearances, maintain commercial general liability and professional liability insurance, and demonstrate documented experience with pharmaceutical handling, patient-monitoring protocols, and compliance with controlled-substance regulations where applicable.

The code shows recent activity in Washington State and Florida. The Washington State Department of Corrections posted RFQQK13020 on September 8, 2026, requesting parenteral products and services for eight correctional facilities across three regions (West, Central, and East), with quotes due October 7, 2026 and a pre-bid conference on September 23, 2026; DOC anticipates awarding up to three contractors per region and requires PN bag delivery within 24 hours of order and other parenteral products within 8 hours. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the contract term runs two years with a one-year renewal option. Both opportunities impose fixed pricing for the initial contract term and require vendors to comply with E-Verify, drug-free workplace certification, and federal environmental regulations where FEMA funding applies.